Patterns of lymph node metastasis are different in colon and rectal carcinomas

被引:53
作者
Wang, Hao [1 ]
Wei, Xian-Zhao [1 ]
Fu, Chuan-Gang [1 ]
Zhao, Rong-Hua [2 ]
Cao, Fu-Ao [1 ]
机构
[1] Second Mil Med Univ, Dept Colorectal Surg, Changhai Hosp, Shanghai 200433, Peoples R China
[2] Univ Saskatchewan, Dept Surg, Coll Med, Saskatoon, SK S7N 0W8, Canada
关键词
Lymph node; Metastasis; Colon; Rectum; Neoplasms; COLORECTAL-CANCER; ADENOCARCINOMA; STAGE; RATIO; PROGNOSIS; SURVIVAL; HARVEST; RISK;
D O I
10.3748/wjg.v16.i42.5375
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
AIM: To describe patterns of lymph node metastasis in invasive colon and rectal carcinomas. METHODS: Clinical data of 2340 patients with colorectal carcinoma (stage I to III) win received radical resection, was retrospectively reviewed. Of the 2340 patients, 1314 patient; suffered from rectal carcinoma and 1026 from colon carcinoma. Patients with rectal cancer who received neoadjuvant chemoradiation therapy were excluded. Statistical analysis was performed using Mann-Whitney, chi(2) and Cochran's one Mantel-Haenszel tests (SPSS 15.0). A two-tailed P < 0.05 was considered statistically significant. RESULTS: Lymph node retrieval in the rectal carcinoma group was significantly lower than that in the colon carcinoma group (P < 0.001), while positive lymph node retrieval in the rectal carcinoma group was significantly higher than that in the colon carcinoma group (P < 0.001). The proportion of lymph node positive (N+) cases was higher (patients with one or more positive lymph nodes) in the rectal carcinoma group (P = 0.004). The number of N+ cases was compared at different T stages (T1-T4) to eliminate background bias and the results were confirmed (P < 0.001). In addition, the lymph node ratio (the ratio of number of positive lymph nodes over the number of lymph nodes examined) of stage III cases in the rectal carcinoma group was significantly higher than that in the colon carcinoma group (P < 0.001). CONCLUSION: Rectal carcinomas seem more prone to metastasize to the lymph nodes than colon carcinomas, which may be of potential clinical significance. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码:5375 / 5379
页数:5
相关论文
共 23 条
[1]
Intersphincteric resection for very low rectal adenocarcinoma: Univariate and multivariate analyses of risk factors for recurrence [J].
Akasu, Takayuki ;
Takawa, Masashi ;
Yamamoto, Seiichiro ;
Ishiguro, Seiji ;
Yamaguchi, Tomohiro ;
Fujita, Shin ;
Moriya, Yoshihiro ;
Nakanishi, Yukihiro .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (10) :2668-2676
[2]
Caplin S, 1998, CANCER, V83, P666, DOI 10.1002/(SICI)1097-0142(19980815)83:4<666::AID-CNCR6>3.0.CO
[3]
2-I
[4]
Tropomyosin3 overexpression and a potential link to epithelial-mesenchymal transition in human hepatocellular carcinoma [J].
Choi, Hye-Sun ;
Yim, Seon-Hee ;
Xu, Hai-Dong ;
Jung, Seung-Hyun ;
Shin, Seung-Hun ;
Hu, Hae-Jin ;
Jung, Chan-Kwon ;
Choi, Jong Young ;
Chung, Yeun-Jun .
BMC CANCER, 2010, 10
[5]
Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer [J].
Chok, Kenneth S. H. ;
Law, Wai Lun .
WORLD JOURNAL OF SURGERY, 2007, 31 (07) :1485-1490
[6]
Edge SB., 2010, AJCC CANC STAGING MA
[7]
Up-regulation of α-catenin is associated with increased lymph node involvement in colorectal cancer [J].
Elzagheid, Adam ;
Buhmeida, Abdelbaset ;
Korkeila, Eija ;
Collan, Yrjo ;
Syrjanen, Kari ;
Pyrhonen, Seppo .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (31) :4903-4908
[8]
A new TNM staging strategy for node-positive (Stage III) colon cancer - An analysis of 50,042 patients [J].
Greene, FL ;
Stewart, AK ;
Norton, HJ .
ANNALS OF SURGERY, 2002, 236 (04) :416-421
[9]
GREENE FL, 2002, AJCC CANC STAGING MA, P113
[10]
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: A pooled analysis [J].
Gunderson, LL ;
Sargent, DJ ;
Tepper, JE ;
Wolmark, N ;
O'Connell, MJ ;
Begovic, M ;
Allmer, C ;
Colangelo, L ;
Smalley, SR ;
Haller, DG ;
Martenson, JA ;
Mayer, RJ ;
Rich, TA ;
Ajani, JA ;
MacDonald, JS ;
Willett, CG ;
Goldberg, RM .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) :1785-1796